1.58 USD
▼-0.14-8.43%
盘后 1.72 0.00%
2026-09-16
市值
$10.65M
市盈率
—
EPS
-0.01
股息率
—
52 周区间
1.16 – 14.10
成交量
71.61K
Beta
-0.53
目标价
—
52W 低 1.1652W 高 14.10
价格走势
公司简介
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin recept...